Lipid Nanoparticles Development Summit Europe

Memo

The LNP Development Europe Summit is the only European conference solely dedicated to LNP formulation and process development to enable seamless scale-up, keeping GMP compliance and manufacturing. Given the rapid developments in the field and the success of Pfizer / BioNTech's mRNA vaccine, lipid nanoparticles have finally reached an inflection point. With new technologies and advancements, LNPs are now a commercially viable delivery vehicle with clinical utility. We have only scratched the surface of the applications of lipid nanocarriers. The past 24 months saw a wave of innovations to exploit the use of LNP beyond mRNA vaccines. Within Europe in 2022, we have witnessed huge investments to establish LNP Centres of Excellence, LNP GMP production facilities in Germany, UK, Spain and funded projects by the European Commission in Belgium. Emulating the success of our US Summit, we have built this European agenda with experts across CSL Behring, Janssen, AstraZeneca, CPI, Insmed and more. The LNP Development Summit aims to bring the formulation and process development experts within the LNP community together to exploit future potential. URLs:Tickets: https://go.evvnt.com/1232239-1?pid=5569 Brochure: https://go.evvnt.com/1232239-3?pid=5569  Date and Time: On Tue, Oct 18, 2022 ( 9:00 AM) - Thu, Oct 20, 2022 ( 5:00 PM) Venue details: DoubleTree by Hilton London - Tower of London, 7 Pepys Street, London, England, EC3N 4AF, United Kingdom Prices:Industry Pricing - Conference + 2 Workshops: GBP 3397.00,Industry Pricing - Conference + 1 Workshop: GBP 2998.00,Industry Pricing - Conference Only: GBP 2599.00,Academic Research Institute Pricing - Conference + 2 Workshops: GBP 2697.00,Academic Research Institute Pricing - Conference + 1 Workshop: GBP 2398.00,Academic Research Institute Pricing - Conference Only: GBP 2099.00,Solution Provider Pricing - Conference + 2 Workshops: GBP 3997.00,Solution Provider Pricing - Conference + 1 Workshop: GBP 3498.00,Solution Provider Pricing - Conference Only: GBP 2999.00 Speakers: Mostafa Nakach, Head of Formulation and Process Development, Sanofi, Ruchi Shah, Associate Director, Eli Lilly and Company, Shahid Uddin, Senior Director of Formulation and Stability, Immunocore, Shashank Pinnapireddy, Head of Nanoparticle Research, CSL Behring, Sune Andersen, Principal Scientist in Particle Engineering, Janssen, Julianna Haggerty, Head of Center of Excellence - LNP, CPI, Dimitrios A. Lamprou, Professor (Chair) of Biofabrication and Advanced Manufacturing, Queens University Belfast, Geoffrey Prevot, Formulation Project Manager, Servier, Michael Munson, Senior Research Scientist, AstraZeneca, Sanyogitta Puri, Director, AstraZeneca, Zohreh Amoozgar, Principal Scientist, Sanofi, Pierre-Alexandre Driguez, Head of mRNA Platform - Vitry, Sanofi, Daniel L. Shores, Partner, Rothwell Figg, Driton Vllasaliu, Senior Lecturer in Pharmaceutics, Kings College London, Kristina Friis, Senior Scientist, Advanced Drug Delivery, AstraZeneca, Rob Worsham, Senior Director, Manufacturing Science and Technology, Insmed, Moein Moghimi, Professor, University of Newcastle, Ken Howard, Associate Professor, Aarhus University, Sara Movassaghian, Associate Director, Voyager Therapeutics, Dai Hayward, CEO, Micropore Technologies Ltd., Senior Representative, Precision Nanosystems, Zongyi Li, Post-Doctoral Researcher, University of Manchester, Nikolas N. Daskalakis, Senior Scientist, Advanced Drug Delivery, AstraZeneca